Intrinsic Value of S&P & Nasdaq Contact Us

MediciNova, Inc. MNOV NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
40/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

MediciNova, Inc. (MNOV) has 20 known insider and institutional holders on record. The largest holder is ESSEX WOODLANDS HEALTH VENTURES FUND VI L P with 11,703,704 shares. Other notable holders include Tanabe Holding America Inc. and Izumi Tatsuo.

Over the last 12 months, insiders have made 5 transactions in MNOV stock — 5 buys (valued at $1.76M) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

MNOV Insider Ownership

Top Holder
ESSEX WOODLANDS HEALTH VENTURES FUND VI L P
11,703,704 shares
Buys (12 mo)
5
$1.76M value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Buy 100%
Sell 0%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Essex Woodlands Health Ventures Fund Vi L P 10 Percent Owner 11,703,704 2005-01-28
100%
2 Tanabe Holding America Inc. Officer 5,000,000 2006-10-16
43%
3 Izumi Tatsuo Director 600,000 2013-12-13
5%
4 Iwaki Yuichi President and CEO 450,000 2026-01-20
4%
5 Matsuda Kazuko Chief Medical Officer 350,000 2026-01-20
3%
6 Suzuki Joji Sr. V.p., Finance & Admin. 300,000 2006-01-06
3%
7 Okajima Masatsune VP and Head of Japanese Office 105,000 2019-01-17
1%
8 Obrien Geoffrey Vice President 84,000 2024-01-11
1%
9 Gammans Richard E Sr Chief Development Officer 60,000 2009-02-03
1%
10 Johnson Kirk William Chief Scientific Officer 42,500 2013-05-15
0%
11 Coffee Michael Denis Chief Business Officer 42,500 2013-05-15
0%
12 Locke Kenneth W Chief Scientific Officer 39,000 2008-01-09
0%
13 Asako Shintaro Chief Financial Officer 35,700 2010-02-02
0%
14 Gaeta Federico C.a. Chief Scientific Officer 24,000 2021-04-26
0%
15 Ishizaka Yoshio Director 20,000 2019-06-11
0%
16 Kobayashi Yutaka Director 20,000 2020-06-17
0%
17 Nagao Hideki Director 20,000 2025-06-20
0%
18 Beaver Carolyn Director 20,000 2025-06-20
0%
19 Lemerond Nicole Director 20,000 2025-06-20
0%
20 Shigeta Hiroaki Director 14,000 2011-07-20
0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-01-16 Matsuda Kazuko Chief Medical Officer RSU Award 350,000 $2.10 $735K
2026-01-16 Iwaki Yuichi President and CEO RSU Award 450,000 $2.10 $945K
2025-06-17 Lemerond Nicole Director RSU Award 20,000 $1.26 $25.2K
2025-06-17 Beaver Carolyn Director RSU Award 20,000 $1.26 $25.2K
2025-06-17 Nagao Hideki Director RSU Award 20,000 $1.26 $25.2K
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message